0 items
CHECKOUT
 Latest News
 Quick Search
 Personal Profiles
 Current Events
 Industry News
 Managed Profiles
 Simple Search
 Advanced Search
 Recent Queries
 Companies By Industry
 Corporate Surveys
 Predecessor & Defunct
 Corporate Analyzer
 Investor Reports
 Historical Reports
 Industry Reports
 Dividends
 New Issues
 Mergers & Acquisitions
 Directory of Directors
 Additional Databases
 Person Search
 Global Search
 Lead List Generator
 Browse Radio
 Search Radio
 Browse Television
 Search Television
 Television Profiles
Company Snapshot

COMPANY INFORMATION
Angiotech Pharmaceuticals, Inc.
1618 Station St
Vancouver, BC
V6A 1B6
Tel: (604) 221-7676
Fax: (604) 221-2330

Contact Name
DeDe Sheel

Industry
Biotechnology
 

Key Executives
William L. Hunter, CEO
K. Thomas Bailey, CFO

Develops and commercializes medical device coatings and treatments for chronic inflammatory diseases through the combination of pharmaceutical compounds with medical devices and biomaterials. Lead products include paclitaxel-eluting coronary stent systems, paclitaxel-eluting mesh, paclitaxel-eluting peripheral vascular stent and self-retaining polydioxanone systems.
FP ADVISOR COVERAGE
Angiotech Pharmaceuticals, Inc.
FP Corporate Analyzer
FP Directory of Directors
FP Corporate Surveys
FP Investor Reports
Ordering FP Products
 
TOP INDUSTRY PLAYERS
Biotechnology
Company NameRevenue ($000s) 
Atrium Innovations Inc. 309,546
Angiotech Pharmaceuticals, Inc. 302,251
QLT Inc. 132,457
Oncothyreon Inc. 42,678
AEterna Zentaris Inc. 41,056
(Links are to Snapshots.)
 
FINANCIAL RATIOS AS OF FEB 5/10
Listed Close 52-wk
High
52-wk
Low
IAD Latest
Dividend
Yield 60-mo
Beta
TSX/ANP
Nasdaq/ANPI
$1.13 $3.10 $0.35 n.a. n.a. n.a. 3.74
Avg 20-day
Volume
P/E 12-mo
EPS
EPS
Date
1-yr
Return
3-yr
Return
5-yr
Return
Market
Cap. (000s)
69,573 n.a. US$-0.99 Sept. 30/09 88.33% -49.3% -45.04% $96,206
 
ANNUAL FINANCIALS
Periods ended: 12m Dec. 31/08A 12m Dec. 31/07A 12m Dec. 31/06A
US$000s US$000s US$000s
Operating revenue 283,272 287,694 315,075
Net income (741,176) (65,940) 4,585
Total assets 385,197 1,150,108 1,205,874
US$ US$ US$
Earnings per share* (8.71) (0.78) 0.05
% % %
Return on equity n.m. (12.12) 2.60
 
* Common
A Reported in accordance with U.S. GAAP
 
TRAILING 12-MONTH VALUES
Periods ended: Sept. 30/09A Sept. 30/08A
US$000s US$000s
Operating revenue 278,199 292,550
Net income (84,199) (692,068)
US$ US$
Earnings per share (0.99) (8.14)
 
A Reported in accordance with U.S. GAAP

COMPANY NEWS
Results for 'Angiotech Pharmaceuticals, Inc.' from past 30 days:
No hits.


(Links are to articles.)


© 2006-2010 Canwest Digital Media, a division of Canwest Publishing Inc. All Rights Reserved. Copyright | Terms Of Use | Privacy Statement